Navigation Links
Cholesterol Drug Fails to Slow Progression of Coronary Disease,,Cleveland Clinic Study Reports

P Inhibition and HDL Elevation" (ILLUSTRATE) trial. All patients had a clinical indication for cardiac catheterization, had a baseline intravascular ultrasound (IVUS) and received 10-80 gm of atorvastatin adjusted during a two- to 10-week period until LDL levels reached national guidelines.

Patients were then randomized to receive either 60 mg of torcetrapib or a matching placebo for two years. At the end of the treatment period, a second IVUS was performed, examining the same coronary arteries. Researchers measured the change in plaque volume in the artery, comparing the baseline to the follow-up ultrasound. They also measured patients' blood cholesterol levels and biomarkers of inflammation at several points during the trial.

Patients in the torcetrapib/atorvastatin group experienced a 61 percent relative increase in HDL cholesterol levels and a 20 percent relative decrease in LDL levels, as compared with patients in the atorvastatin-only group. Despite those results, there was no statistical difference between the two groups in plaque volume changes. Plaque volume increased by 0.19 percent in the atorvastatin-only patients and 0.12 percent in the combination group, p = 0.72. Torectrapib was also associated with a substantial increase in blood pressure, averaging 4.6 mm.

IVUS is a technique in which a tiny ultrasound probe is inserted into the coronary arteries, providing a precise and reproducible method for determining the change in plaque, or atheroma, burden during treatment.

Cleveland Clinic, located in Cleveland, Ohio, is a not-for-profit multispecialty academic medical center that integrates clinical and hospital care with research and education. Cleveland Clinic was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. U.S. News & World Report consistently names Cleveland Clinic as one of the nation's best hospitals
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Low-Density Cholesterol Subfractions: Not all LDL-C Particles are Created Equal
2. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
3. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
4. KineMed Presents Data Measuring Changes in Reverse Cholesterol Transport for the First Time
5. CSL Therapy That Mimics “Good” Cholesterol May Reduce Plaque Volume in Coronary Arteries
6. CSL Therapy That Mimics Good Cholesterol May Reduce Plaque Volume in Coronary Arteries
7. Treating Heart Disease Risk Factors May Slow Alzheimers Disease Progression
8. Caelyx Delays Time to Disease Progression as Maintenance Therapy in Patients with Metastatic Breast Cancer
9. Merck at ASCO 2007: Encouraging Results in Progression-Free Survival in Patients With Aggressive Brain Tumors (glioblastoma) Using Cilengitide in Phase I/IIa Study
10. The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved Progression Free Survival When Given Before and After Surgery in Patients With Resectable Liver Metastases From Colorectal Cancer
11. Multiferon Shows Potent Activity in Preventing the Progression of Malignant Melanoma; Study to be Published
Post Your Comments:
(Date:6/30/2015)... /PRNewswire/ – Small Cap IR issues report. Recently, Arrayit ... Arrayit blood card technology to Vivos, Global Genome Vault, ... offers an impervious, impenetrable and permanent DNA storage vault, ... on Earth, a safe and secure nuclear blast-proof, underground ... the rapid collection, separation, drying and storage of human ...
(Date:6/30/2015)... , June 30, 2015  Egalet Corporation ... integrated specialty pharmaceutical company focused on developing, ... announced top-line results from a Category 3 ... an abuse-deterrent, extended-release, oral oxycodone product candidate ... of pain severe enough to require daily, ...
(Date:6/30/2015)... 2015 PharmaVentures is pleased to ... Technologies Oy (CMT) on its divestment of certain assets ... CMTs world leading capabilities in cellular imaging and analysis. ... series of successful global deals in the life science ... Fintan Walton , CEO, PharmaVentures, commented: "PharmaVentures is delighted ...
Breaking Medicine Technology:Small Cap IR - Empowering the Age of Genetic Enlightenment 2Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 2Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 3Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 4Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 5PharmaVentures Completes M&A Deal for Technology in the Stem Cell & Regenerative Medicine Sector 2
(Date:6/30/2015)... ... July 01, 2015 , ... Popular review ... to navigate. By making fundamental changes to the UI, the website hopes to ... said, “Finding the right website has been getting tougher. People are seeking professional ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... As a subcontractor, ESSC ranked as one of their top 20 installing dealers ... last quarter of 2014. Providers are based on timeliness, service, installation, paperwork and ...
(Date:6/30/2015)... ... 2015 , ... Ticket Down announces that they have slashed prices across the board for the ... For the past 26 years, “The Phantom of the Opera” has been a hit ... by Gaston Leroux, and converted into a musical by Andrew Lloyd Webber won a Tony ...
(Date:6/30/2015)... ... , ... Ticket Down is a reliable source for last minute tickets for The Rolling ... stadiums across North America in conjunction with their 2015 “Zip Code Tour.” , The Stones ... band in their twenties. Some of the most beloved songs that this iconic group ...
(Date:6/30/2015)... ... June 30, 2015 , ... The board certified otolaryngologists ... design’ website to inform potential sinus surgery patients about ear, nose, and throat ... information about a wide variety of ENT issues including hearing loss, ear infections, ...
Breaking Medicine News(10 mins):Health News:HerpesDatingSites.org Introduces a New Responsive Design 2Health News:Electronic Security Specialists (E.S.S.C. Inc) Awarded Top Service Provider Award By Monitronics 2Health News:Phantom of the Opera Tickets at The Pantages Theatre in Los Angeles: Ticket Down Has Slashed Prices On All Phantom of the Opera Tickets in LA at The Pantages Theatre 2Health News:The Rolling Stones Tickets in Raleigh at Carter Finley Stadium: Ticket Down Offers Last Minute Tickets for the Rolling Stones and Avett Brothers in Raleigh 2Health News:Clear Lake Medical Center ENT Launches ‘Responsive Design’ Website 2Health News:Clear Lake Medical Center ENT Launches ‘Responsive Design’ Website 3
... epidemic has entered a disturbing new phase, with a study ... the sharp rise in the number of cases. , A ... South Wales (UNSW), believe this emerging new genotype (called ... evading the protective effects of the current acellular vaccine (ACV), ...
... Arabic have more challenges reading in Arabic than native Hebrew ... two halves of the brain divide the labor differently when ... English. That is the result of a new study conducted ... the Edmond J. Safra Brain Research Center for the Study ...
... of anesthesia providers to monitor sedation during screening colonoscopies ... 2003 to 2009 in the United States, with most ... need this service, according to a new RAND Corporation ... $1.1 billion spent annually on anesthesia services for GI-related ...
... Austria: New research has shown for the first time that ... oestrogen receptor positive breast cancer to become pregnant, despite doctors, ... the body and cause the cancer to return. In ... eighth European Breast Cancer Conference (EBCC-8) in Vienna, suggest that ...
... TUESDAY, March 20 (HealthDay News) -- Calculating the ... and right arms might help predict a patient,s odds ... Researchers found that people with high blood pressure ... at higher risk of cardiovascular death over 10 years. ...
... a consortium of investigators from 13 countries led the University ... Catholic University of Leuven, Belgium in Europe, found that nurses ... of leaving also had patients who were more satisfied with ... study was released today in the current issue of the ...
Cached Medicine News:Health News:Sharp rise in cases of new strain of whooping cough 2Health News:Sharp rise in cases of new strain of whooping cough 3Health News:Brain's involvement in processing depends on language's graphic symbols 2Health News:Brain's involvement in processing depends on language's graphic symbols 3Health News:Use of anesthesia providers during GI procedures is growing, but may be unnecessary 2Health News:Pregnancy is safe for women with estrogen receptor positive breast cancer 2Health News:Pregnancy is safe for women with estrogen receptor positive breast cancer 3Health News:Pregnancy is safe for women with estrogen receptor positive breast cancer 4Health News:Blood Pressure Variance Between Arms Points to Heart Risk 2Health News:International research finds quality and safety problems in hospitals throughout 13 countries 2
Telescopic Diamond-Dissectors for delicate sharp tissue preparation. Total/working lengths 220/240 mm with protective sleeve....
Epstein Curettes 3.0 mm, length 8" (203 mm)....
Cobb Spinal Curettes, tip size 13.00 mm, length 11" (279 mm)....
Karlin XL Magnum Ring Curettes, extra long (XL) curettes, black handles, lightweight. Length 13 1/4" (33.7 cm), handle length 8 1/2" (21 cm), handle diameter 1 1/4" (32 cm)....
Medicine Products: